|
Real-time Estimate
Tradegate
06:32:24 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 9.040 EUR | -1.31% |
|
-0.44% | +7.43% |
| 08-12 | European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading | MT |
| 08-12 | Nordic stocks in North America: AstraZeneca fell 1.0% | FW |
Company Valuation: ERICSSON
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 332,382 | 204,141 | 210,346 | 299,520 | 301,970 | 321,503 | - | - |
| Change | - | -38.58% | 3.04% | 42.39% | 0.82% | 6.47% | - | - |
| Enterprise Value (EV) 1 | 297,231 | 189,986 | 212,445 | 281,130 | 278,032 | 272,336 | 263,209 | 256,208 |
| Change | - | -36.08% | 11.82% | 32.33% | -1.1% | -2.05% | -3.35% | -2.66% |
| P/E | 14.7x | 10.8x | -7.95x | 8,988x | 10.6x | 18.4x | 15.7x | 14.2x |
| PBR | 3.06x | 1.51x | 2.16x | 3.18x | 2.76x | 2.92x | 2.73x | 2.54x |
| PEG | - | -0.6x | 0x | -90x | 0x | -0.5x | 0.9x | 1.4x |
| Capitalization / Revenue | 1.43x | 0.75x | 0.8x | 1.21x | 1.28x | 1.42x | 1.4x | 1.37x |
| EV / Revenue | 1.28x | 0.7x | 0.81x | 1.13x | 1.17x | 1.2x | 1.14x | 1.09x |
| EV / EBITDA | 7.2x | 5x | 7.06x | 5.58x | 5.54x | 7.24x | 6.92x | 6.44x |
| EV / EBIT | 9.2x | 6.93x | 11.7x | 11.4x | 6.79x | 9.2x | 8.78x | 8.14x |
| EV / FCF | 8.37x | 7.13x | 54.8x | 6.4x | 10.4x | 11.9x | 10.1x | 9.66x |
| FCF Yield | 11.9% | 14% | 1.83% | 15.6% | 9.63% | 8.39% | 9.91% | 10.4% |
| Dividend per Share 2 | 2.5 | 2.5 | 2.7 | 2.85 | 3 | 3.063 | 3.176 | 3.32 |
| Rate of return | 2.51% | 4.11% | 4.28% | 3.17% | 3.31% | 3.13% | 3.25% | 3.4% |
| EPS 2 | 6.81 | 5.62 | -7.94 | 0.01 | 8.51 | 5.306 | 6.248 | 6.882 |
| Distribution rate | 36.7% | 44.5% | -34% | 28,500% | 35.3% | 57.7% | 50.8% | 48.2% |
| Net sales 1 | 232,314 | 271,546 | 263,351 | 247,880 | 236,681 | 226,153 | 230,405 | 235,282 |
| EBITDA 1 | 41,298 | 37,962 | 30,084 | 50,358 | 50,212 | 37,622 | 38,042 | 39,778 |
| EBIT 1 | 32,300 | 27,419 | 18,093 | 24,658 | 40,971 | 29,592 | 29,966 | 31,473 |
| Net income 1 | 23,000 | 18,724 | -26,446 | 20 | 28,428 | 17,844 | 20,326 | 21,797 |
| Net Debt 1 | -35,151 | -14,155 | 2,099 | -18,390 | -23,938 | -49,167 | -58,294 | -65,294 |
| Reference price 2 | 99.79 | 60.90 | 63.11 | 89.88 | 90.60 | 97.78 | 97.78 | 97.78 |
| Nbr of stocks (in thousands) | 3,329,738 | 3,330,142 | 3,330,142 | 3,332,672 | 3,333,287 | 3,283,682 | - | - |
| Announcement Date | 1/25/22 | 1/20/23 | 1/23/24 | 1/24/25 | 1/23/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 38.11x | 7.96x | 20.55x | 1.34% | 488B | ||
| 55.44x | 19.74x | 39.62x | -.--% | 265B | ||
| 22.11x | 0.88x | 15.87x | 2.09% | 193B | ||
| 32.38x | 10.18x | 25.06x | 0.34% | 160B | ||
| 188.79x | 27.66x | 81.09x | -.--% | 82.62B | ||
| 34.07x | 6.59x | 18.82x | 0.99% | 77.74B | ||
| 83.01x | 9.67x | 44.63x | -.--% | 61.16B | ||
| 30.97x | 7.03x | 23.52x | 1.33% | 59.78B | ||
| 43.07x | 2.28x | 14.83x | 1.67% | 58.22B | ||
| Average | 58.66x | 10.22x | 31.56x | 0.86% | 160.7B | |
| Weighted average by Cap. | 48.71x | 10.28x | 28.20x | 0.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ERIC B Stock
- ERCG Stock
- Valuation ERICSSON
Select your edition
All financial news and data tailored to specific country editions
















